Skip to Content

Value The Markets

Stock Market Review for the Retail Investor

Tag

Pharmaceuticals

Open Orphan extends pharmacometrics relationship with tier 1 German pharma company
30 Oct 2020
Open Orphan reveals transformational Covid-19 vaccine contract with UK government
20 Oct 2020
Open Orphan hits record highs after winning £4.3m vaccine contract
28 Sep 2020
Round-up: Busy week for Open Orphan as it pushes forward Covid and oncology arms (ORPH)
25 Sep 2020
Special Report: 6 Reasons Why XPhyto Therapeutics Can Enhance Your Portfolio – (CSE:XPHY | OTC:XPHYF | FSE:4XT)
06 Aug 2020
Key human challenge expert Adrian Wildfire rejoins hVIVO for Open Orphan boost (ORPH)
15 Jul 2020
Open Orphan’s hVIVO expands lab growth revenue with three new contract wins (ORPH)
07 Jul 2020
Open Orphan hits accumulation stage with operational profitability slated for Q3 2020 (ORPH)
01 Jul 2020
XPhyto (CSE:XPHY│OTC:XPHYF) – an exhilarating biotech company with Big Pharma potential!
25 Jun 2020
Open Orphan share price spikes as Covid-19 home testing stocks rocket (ORPH)
18 May 2020
Open Orphan races ahead with £3.5m US human challenge study contract (ORPH)
04 May 2020
Omega Diagnostics ramps up Covid-19 antibody tests to 1 million a month, could fly higher (ODX)
22 Apr 2020
Open Orphan’s Cathal Friel on firm’s “milestone” human coronavirus challenge study (ORPH)
09 Mar 2020
Open Orphan signs £3.2m challenge study deal with upside potential (ORPH)
06 Mar 2020
First profits and underlying business growth make YourGene a buy (YGEN)
04 Mar 2020
Open Orphan primed to support coronavirus vaccine work after bringing in world-leading experts (ORPH)
27 Feb 2020
Coronavirus test maker Novacyt rockets 900% but investors get sinking feeling (NCYT)
19 Feb 2020
VIDEO: Open Orphan’s Cathal Friel details ambitious 2020 plans following £5.3m raise in exclusive presentation (ORPH)
12 Feb 2020
Cathal Friel hails “once in a lifetime” opportunity as Open Orphan/hVIVO merger passes (ORPH)
16 Jan 2020

teathers app screenshot

App Empowering Private Investors

Crowd Equity for Placings, IPOs and Live Market Blockbuilds, designed to give provate investors access to placements and Intial Public Offerings (IPOs), predominantly on the London Stock Exchange’s Alternative Investment Market (AIM).